Reports and Briefs in Asia-Pacific

Published within

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

Type Product title / description Pub Price
Report
Report

Biosimilars: Japan Update

Datamonitor’s report Biosimilars: Japan Update provides analysis on the Japanese biosimilars market. It includes an overview of drivers and resistors to biosimilars uptake, market access strategies, key players, and future development trends.

Published By Datamonitor
13 Sep 2011 $1900
Buy

Exclusive online offer: order this report by November 9th and save 20%

To take advantage of this offer enter Promo Code BIO2012 when prompted in the checkout

More information

Report
Report

Biosimilars: Market Entry Strategies

This report provides an analysis of strategies employed by the top 50 pharma companies that are active or plan to enter the biosimilars sector in the future, together with an analysis of biosimilar deal trends among the top 50 pharma companies.

Published By Datamonitor
20 Dec 2011 $5700
Buy
Report
Report

Biosimilars: Pipeline Trends

The report provides an overview of biosimilar and copy-biologic product landscape, split by marketed and pipeline products, target therapy areas and indications, geography, and drug developers.

Published By Datamonitor
09 Dec 2011 $5700
Buy
Report
Report

Biosimilars: Regulatory Update

Datamonitor’s report Biosimilars: Regulatory Update provides analysis on key developments in biosimilar regulations globally. It includes an overview of the background behind these events and popular strategic responses.

Published By Datamonitor
08 Dec 2011 $1900
Buy
Brief
Brief

Blue Inc | Verdict Company Briefing

A new one-stop destination for unique data and opinion on Blue Inc's clothing offer. Targeted at retailers, and stakeholders to the retailer, we assess its clothing performance, strategic direction and provide Verdict's view on its future.

Published By Verdict
06 Aug 2012 $400
Buy
Brief
Brief

BP Sustainability Case Study

The way oil and gas companies respond to complex sustainability issues is crucial to future energy supply. This brief analyses in-depth how BP responds to those issues and outlines three scenarios for their corporate strategy to 2030.

Published By Datamonitor
29 Jul 2010 $3495
Buy
Report
Report

Brand Positioning in the Indian Consumer Goods Industry: Successful Strategies and Best Practice

This report identifies eight main platforms that have formed the basis of the most significant products launches in Indian market. Through case studies, the report examines the best-in-class innovations and marketing strategy of 25 brands.

Published By Datamonitor
07 Mar 2011 $1495
Buy
Report
Report

Branded Prescription Pharmaceutical Sales Outlook to 2016

An analysis of global sales forecasts for the Branded PharmaVitae Universe during 2011–16.

Published By Datamonitor
03 Feb 2012 $5700
Buy
Report
Report

BRIC: Pricing, Reimbursement, and Regulatory Update

Datamonitor’s report BRIC: Pricing, Reimbursement, and Regulatory Update provides an update of changes to pricing, reimbursement and regulation in Brazil, Russia, India and China during the first half of 2011.

Published By Datamonitor
08 Sep 2011 $1900
Buy
Brief
Brief

Brief: Hepatitis C/AASLD 2010

This brief is an overview of the HCV highlights from the 2010 American Association of the Study of Liver Disease meeting. It discusses pivotal data for telaprevir and boceprevir, results for TMC435 and data from interferon-sparing studies.

Published By Datamonitor
13 Dec 2010 $500
Buy

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

No help is available.